Sbir phase I: an endoscopic 3D imaging system for the evaluation of cancer and other disorders of the esophagus and pharynx

The National Science Foundation awarded Pensievision, Inc. $255,947 under the Technology, Innovation, and Partnerships program (CFDA 47.084) to develop an endoscopic 3D imaging system for evaluating cancers and disorders of the esophagus and pharynx. The Small Business Innovation Research Phase I project will combine liquid lens technology, artificial intelligence software, and astronomical imaging techniques to generate three-dimensional images of early-stage esophageal and throat tumors. This award will specifically support acquiring quality 3D images of a cadaver's esophagus and pharynx in preparation for further testing and development. If successful, the imaging system aims to assist clinicians in detecting such tumors at earlier stages, with potential life-saving effects and positive commercial impact by addressing an annual multi-million dollar market.

Abstract

The broader impact/commercial potential of this small business innovation research (SBIR) phase I project regards the ability to achieve early detection of cancers of the esophagus and throat. This project targets a multimillion-dollar annual market and has the potential to positively impact rural and underserved communities without access to specialty endoscopy clinics. The project also has the potential to positively impact the african american community, where the incidence of esophageal cancer is higher. This small business innovation research (SBIR) phase I project aims to assist clinicians in detecting tumors of the esophagus and throat at an earlier stage, which will have life-saving effects. This project will combine liquid lens technology with artificial intelligence software and astronomical imaging techniques, with the objective of generating three-dimensional images of early stage esophageal and throat tumors. This particular study will focus on acquiring quality three-dimensional images of a cadaver?S esophagus and pharynx to prepare for the next stage of testing and development. This award reflects NSF's statutory mission and has been deemed worthy of support through evaluation using the foundation's intellectual merit and broader impacts review criteria.